Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by rhodiumdon Oct 11, 2024 12:55pm
167 Views
Post# 36262880

RE:RE:RE:Once again... This is it

RE:RE:RE:Once again... This is it

"My thought is our next news release is BTD approval,IMO within 6 weeks because i think preBTD was filed a well over week ago"

 

Agreed. Pre-BTD could have been a done deal the week before the NR as it takes time to prepare and get NR approved before distribution.  MP was very confident about meeting the "pre-BTD before end of Q3 milestone" (as reported by another user). so I believe a call with the FDA was already scheduled or had already happened. 

 

Announcing the BTD application may piss off large investors hoping to get in before all the price jumps. In the end, the application doesn't matter, only the approval does so my belief is that it has been submitted and we'll get fireworks in November or early-December. Also hoping for 90+ patients treated by the end of the year as this time of year is supposedly "busier" in terms of enrollement. 

<< Previous
Bullboard Posts
Next >>